AdamJanOlszewskiMD

PubMed

• 1212 citations
  Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study.
  Nicole M. Kuderer, Toni K. Choueiri, Dimpy P. Shah, Yu Shyr, Samuel M. Rubinstein
  Lancet. 2020-06-20
• 4 citations
  Health Insurance-Related Disparities in Lymphoma Survival Are Partly Mediated by Baseline Clinical Factors
  Adam J. Olszewski, James M. Foran
  The Oncologist. 2015-10-01
• 5 citations
  Clinical features of patients with-deleted bladder cancer.
  Andre L De Souza, Anthony E Mega, John Douglass, Adam J Olszewski, Ece D Gamsiz Uzun
  American Journal of Cancer Research. 2023-01-01

Abstracts/Posters

• BrUOG 345: Fractionated Gemtuzumab Ozogamicin Followed By Non-Engraftment Donor Leukocyte Infusions for Relapsed/Refractory Acute Myeloid Leukemia
  Adam J Olszewski, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Exposure to Ibritumomab Tiuxetan and Incidence of Treatment-Related Myeloid Neoplasms Among Older Patients with B-Cell Lymphoma: A Population-Based Study
  Adam J Olszewski, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• The Evaluation and Treatment (Tx) of Burkitt Lymphoma (BL) in the Modern Era: Real World (RW) Outcomes and Prognostication across 26 US Cancer Centers (CC)
  Adam J Olszewski, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• Billed Palliative Care Services and End-of-Life Care in Patients with Hematologic Malignancies
  Adam J Olszewski, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• Comparative Effectiveness of Lenalidomide, Bortezomib, and Their Combinations As First-Line Treatment of Older Patients with Myeloma
  Adam J Olszewski, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• Outcomes of Patients with Newly-Diagnosed Burkitt Lymphoma (BL) and Central Nervous System (CNS) Involvement Treated in the Modern Era: A Multi-Institutional Real-Worl...
  Adam J Olszewski, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• Outcomes of Patients with Refractory Peripheral T-Cell Lymphoma, Angioimmunoblastic and Other Nodal Lymphomas of T Follicular Helper-Cell Origin (OPerA)
  Adam J Olszewski, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• Evaluating the Incidence of Cardiovascular and Thrombotic Events in Secondary Polycythemia
  Adam J Olszewski, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Geographic Variation in the Incidence of Marginal Zone Lymphoma Subtypes and Infectious Risk Factors in the United States
  Adam J Olszewski, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Extranodal Diffuse Large B Cell Lymphoma: Molecular Features, Prognosis, and Risk of Central Nervous System Recurrence
  Adam Olszewski, MD, Current Treatment Options in Oncology, Orlando, FL, 12/7/2019
• Join now to see all

Lectures

• Tumor-Specific Cell-Free DNA (cfDNA) in the Cerebrospinal Fluid (CSF) Detects Cytologically Occult Central Nervous System (CNS) Involvement in Aggressive Lymphomas 
  61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
• Bendamustine-Rituximab Does Not Improve Survival over Rituximab Monotherapy for Older Patients with Nodal or Splenic Marginal Zone Lymphoma 
  61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
• Loss of Abelson Interactor-1 Is Linked to Inflammatory Hematopoiesis and Accelerated Aging of Hematopoietic System 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
• Hospice use among Medicare fee-for-service (FFS) or managed-care organization (MCO) enrollees with leukemia and myeloma. 
  2018 ASCO Annual Meeting - Chicago, Illinois - 06/4/2018
• Join now to see all